Established · publishing since 1971
Inflammatory mediators and NSAID effectsPancreatic and Hepatic Oncology ResearchHelicobacter pylori-related gastroenterology studiesGallbladder and Bile Duct DisordersAntiplatelet Therapy and Cardiovascular Diseases
Publications
442
Citations
15,370
Est. group size
~2
Recurring co-author estimate
Active years
56
Publishing since 1971
In context
Among 4,953 established Medicine PIs within our index
Citations: 15,370p25 789 · p75 7,423 · cohort median 2,544
Publications / year (recent): 5.6p25 2 · p75 10.6 · cohort median 4.8
Typically publishes in teams of ~9 · 9% small-team papers (≤3 authors) · across 14 venues
Publication cadence
Publications per year over the last 10 years — averaging 5.6/year recently
Recent publications
- Quality measures in the design, conduct, and reporting of endoscopic research
Gastrointestinal Endoscopy · 2026
- S69 Frequency and Predictors of Incomplete Bile Duct Clearance in Hospitalized Patients Receiving ERCP for Choledocholithiasis
The American Journal of Gastroenterology · 2025
- Development and usability of an endoscopist report card assessing ERCP quality
Gastrointestinal Endoscopy · 2024
- Data from Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy
2023
- Supplementary Figure 1B from Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy
2023
- Supplementary Figure Legend from Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy
2023
- Supplementary Figure 3 from Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy
2023
- Supplementary Figure 2 from Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy
2023
- Supplementary Figure 1 A from Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy
2023
- Supplementary Material from Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy
2023
- Supplementary Figure 1 A from Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy
2023
- Data from Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy
2023
- Supplementary Figure 3 from Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy
2023
- Supplementary Figure 2 from Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy
2023
- Supplementary Figure Legend from Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy
2023
Publishes in
- Gastrointestinal Endoscopy×21
- Gastroenterology×16
- The American Journal of Gastroenterology×10
- Clinical Gastroenterology and Hepatology×4
- Pancreas×3
Similar researchers
By research-topic overlap
- Randall E. Harris
Medicine · The Ohio State University
- Maxime A. Gallant
Medicine · Purdue University West Lafayette
- Imad Shureiqi
Medicine · University of Michigan
- F.F. Sun
Medicine · Indiana University
- Randall Harris
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile